Olema Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| OLMA | VSTM | PBYI | AVBP | KZIA | ANL | |
|---|---|---|---|---|---|---|
| Market cap | 659.73M | 1.20B | 551.82M | 665.16M | 92.33M | 618.86M |
| P/E (TTM) | — | — | 21.0 | — | — | — |
| Forward P/E | -2.9 | -8.1 | 30.5 | -3.6 | -1,473.8 | -32.7 |
| Price/book | 1.5 | 17.8 | 3.9 | 1.8 | 2.8 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −7.55% | +24.21% | +118.16% | −26.64% | +7.73% | +520.00% |
| Today | +2.59% | +0.82% | +4.60% | +3.61% | 0.00% | +0.31% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All OLMA news ›Olema Oncology to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema” or "Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted…
Olema Pharmaceuticals (NASDAQ:OLMA) Hits New 52-Week Low – Time to Sell?
Posted by Defense World Staff on Oct 26th, 2026 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) shares reached a new 52-week low during mid-day trading on Saturday. The stock traded as low as $6.24 and last traded at $6.41,…
More from 1 other outlet
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Falls 6.6% – Here’s What Happened
Posted by Michael Walen on Oct 23rd, 2026 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) traded down 6.6% during mid-day trading on Friday. The stock traded as low as $6.55 and last traded at $6.56. 130,638 shares were traded…
Olema Pharmaceuticals: BVF reports roughly 9.8% stake
A 9.99% ownership cap limits warrant exercises at Olema Pharmaceuticals (OLMA). Stock Titan - [SCHEDULE 13D/A] Olema Pharmaceuticals, Inc. Amended Major Shareholder Report Olema Pharmaceuticals: BVF reports roughly 9.8% stake A 9.99%…
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Has Consensus Price Target of $40.60 According to Brokerages
Read Our Latest Research Report on OLMA Olema Pharmaceuticals (NASDAQ:OLMA - Get Free Report) last posted its earnings results on Monday, August 10th. The company reported ($0.61) EPS for the quarter, missing the consensus estimate of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com2
- defenseworld.net1
- manilatimes.net1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.